“EST73502” (ESTEVE oral dual mu-opioid receptor agonist, sigma-1 receptor antagonist clinical candidate)
< 1 minute read
Sep. 18, 2021
EST73502: A Dual µ-Opioid Receptor Agonist, σ1 Antagonist
"EST73502"
dual µ-opioid receptor agonist, σ1 antagonist oral analgesia w/ reduced opioid AEs, in Ph. I from literature cmpd pharmacophore merging J. Med. Chem., Oct. 16, 2020 ESTEVE Pharmaceuticals SA, Barcelona, ES